APA

Freytes C. O., Vesole D. H., LeRademacher J., Zhong X., Gale R. P., Kyle R. A., Reece D. E., Gibson J., Schouten H. C., McCarthy P. L., Lonial S., Krishnan A. Y., Dispenzieri A. & Hari P. N. (20150702). Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantation. : Bone marrow transplantation.

Chicago

Freytes C O, Vesole D H, LeRademacher J, Zhong X, Gale R P, Kyle R A, Reece D E, Gibson J, Schouten H C, McCarthy P L, Lonial S, Krishnan A Y, Dispenzieri A and Hari P N. 20150702. Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantation. : Bone marrow transplantation.

Harvard

Freytes C. O., Vesole D. H., LeRademacher J., Zhong X., Gale R. P., Kyle R. A., Reece D. E., Gibson J., Schouten H. C., McCarthy P. L., Lonial S., Krishnan A. Y., Dispenzieri A. and Hari P. N. (20150702). Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantation. : Bone marrow transplantation.

MLA

Freytes C O, Vesole D H, LeRademacher J, Zhong X, Gale R P, Kyle R A, Reece D E, Gibson J, Schouten H C, McCarthy P L, Lonial S, Krishnan A Y, Dispenzieri A and Hari P N. Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantation. : Bone marrow transplantation. 20150702.